Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoping Su

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
Histopathology|January 21, 2017
Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomasMarion Classe, Gabriel G Malouf, Xiaoping Su, et al.
EMBO Molecular Medicine|March 28, 2025
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinomaAlexandra Helleux, Guillaume Davidson, Antonin Lallement, et al.
Cancer Cell|October 18, 2005
Radial glia cells are candidate stem cells of ependymomaMichael D Taylor, Helen Poppleton, Christine Fuller, et al.
Oncotarget|October 3, 2015
Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrationsYunyun Jiang, Gabriel G Malouf, Jianping Zhang, et al.
Nature Communications|November 30, 2023
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumorsXiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, et al.
The Lancet. Oncology|January 17, 2009
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaElaine Coustan-Smith, Charles G Mullighan, Mihaela Onciu, et al.
Endocrine-Related Cancer|March 28, 2013
In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomasRodrigo A Toledo, Yuejuan Qin, Subramanya Srikantan, et al.
Cancers|May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary CarcinomaAndrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Frontiers in Neurology|April 21, 2023
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profilesLea M Stitzlein, Achintyan Gangadharan, Leslie M Walsh, et al.
Frontiers in Molecular Biosciences|May 3, 2021
Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6Pan Li, Zhengmao Lu, Qiang Li, et al.
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
Histopathology|January 21, 2017
Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomasMarion Classe, Gabriel G Malouf, Xiaoping Su, et al.
EMBO Molecular Medicine|March 28, 2025
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinomaAlexandra Helleux, Guillaume Davidson, Antonin Lallement, et al.
Cancer Cell|October 18, 2005
Radial glia cells are candidate stem cells of ependymomaMichael D Taylor, Helen Poppleton, Christine Fuller, et al.
Oncotarget|October 3, 2015
Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrationsYunyun Jiang, Gabriel G Malouf, Jianping Zhang, et al.
Nature Communications|November 30, 2023
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumorsXiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, et al.
The Lancet. Oncology|January 17, 2009
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaElaine Coustan-Smith, Charles G Mullighan, Mihaela Onciu, et al.
Endocrine-Related Cancer|March 28, 2013
In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomasRodrigo A Toledo, Yuejuan Qin, Subramanya Srikantan, et al.
Cancers|May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary CarcinomaAndrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Frontiers in Neurology|April 21, 2023
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profilesLea M Stitzlein, Achintyan Gangadharan, Leslie M Walsh, et al.
Frontiers in Molecular Biosciences|May 3, 2021
Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6Pan Li, Zhengmao Lu, Qiang Li, et al.
Pageof 20